CHEK2 and neoplasm: Additionally, CHK2 inhibitors specifically interfere with DDR pathways in tumor cells and promote tumor cell apoptosis by disrupting cell cycle regulatory networks, effectively inhibiting tumor progression, thereby significantly enhancing the therapeutic effects of conventional chemotherapeutic agents.